Fox Chase Cancer Center Receives Grant From The Bell Atlantic Foundation
PHILADELPHIA (January 31, 2000) -- Fox Chase Cancer Center announces a $5,000 grant from the Bell Atlantic Foundation to help support its bioinformatics facility and contribute to the Center's effort in advancing the science of cancer prevention.
Bioinformatics is the use of advanced computing techniques to manage and analyze biological data. Bioinformatics is particularly important to Fox Chase's genomics research because of the large amount of complex data it generates.
By 2003, scientists at Fox Chase and elsewhere expect the international Human Genome Project to have identified virtually all of our 100,000 genes, decoding the complete sequence of our three billion subunits of DNA. This knowledge will speed identification of many more genes associated with specific cancers and other diseases.
"This grant demonstrates the Bell Atlantic Foundation's commitment to the health of the community it serves," said Frank Manion, Dir. of Research Information Technology at Fox Chase. "The application of bioinformatics will allow researchers to develop new insights into the complex genetic mechanisms underlying cancer. Ultimately, this will lead to greatly improved cancer risk assessment and prevention programs, earlier disease detection, and better treatment for people with cancer."
"The Bell Atlantic Foundation is proud to partner with Fox Chase Cancer Center in its vital health care research," said Lynn Sheppard, Director-External Affairs, Bell Atlantic - Pennsylvania. "We are confident that the efforts of the Bioinformatics Center will make great strides to help individuals in the fight against cancer and we are happy to support its fine work."
The Bell Atlantic Foundation supports a variety of projects domestically and internationally, with an emphasis on new technology applications in education, health and human services, the arts and humanities, and civic development in the communities served by Bell Atlantic. For more information, visit www.bellatlanticfoundation.com on the internet.
Fox Chase Cancer Center, one of the nation's first comprehensive cancer centers designated by the National Cancer Institute in 1974, conducts basic and clinical research; programs of prevention, detection and treatment of cancer; and community outreach. For more information about Fox Chase activities, visit the Center's web site at www.fccc.edu.
Fox Chase Cancer Center, part of the Temple University Health System, is one of the leading cancer research and treatment centers in the United States. Founded in 1904 in Philadelphia as one of the nation’s first cancer hospitals, Fox Chase was also among the first institutions to be designated a National Cancer Institute Comprehensive Cancer Center in 1974. Fox Chase researchers have won the highest awards in their fields, including two Nobel Prizes. Fox Chase physicians are also routinely recognized in national rankings, and the Center’s nursing program has received the Magnet recognition for excellence four consecutive times. Today, Fox Chase conducts a broad array of nationally competitive basic, translational, and clinical research, with special programs in cancer prevention, detection, survivorship, and community outreach. For more information, call 1-888-FOX CHASE or (1-888-369-2427).
Media inquiries only, please contact Jeremy Moore at 215-728-2700.